Ira Khanna, MBBS

Ira Khanna practices at Madison Surgical Obs, LLC in New York, New York.

Ira Khanna's NPI, 1861924847, was assigned on March 30, 2017. Ira Khanna holds New York license 306410.

Ira Khanna's primary practice is Madison Surgical Obs, LLC, at 425 W 59th St, New York, NY 10019 in New York County. The practice phone is (212) 523-8417.

Ira Khanna's primary practice is Madison Surgical Obs, LLC in New York, New York. Ira Khanna is also affiliated with Mount Sinai West. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Ira Khanna to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ira Khanna practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Ira Khanna's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Ira Khanna is licensed in New York.

CMS data shows 400 Medicare services from Ira Khanna across 5 procedure codes in 2024, for 130 Medicare patients. Medicare paid $25,215 for them. Every service was in an office.

CMS counts 130 Medicare patients who saw Ira Khanna in 2024. The largest group is 65 to 74, with 55 patients. 75% of them have high cholesterol, and 73% have arthritis. 26% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ira Khanna's median patient age at 61, with 75% women.

In 2024, Ira Khanna wrote 977 Medicare Part D claims for 175 patients. 91% of them were for generic drugs. CMS names the drug for 873 of them, across 16 drugs with 11 or more claims each, at $17,317 in total drug cost. In 2023, CMS named 559 claims across 15 drugs.

Ira Khanna accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ira Khanna as offering telehealth.

CMS Open Payments shows 6 general payments to Ira Khanna from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $69.